WORK EXPERIENCE

Head, International Healthcare Services

March 2024 – Present
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Deputy Director, Neuroscience Center
June 2021 – Present
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Board Member, Saudi Movement Disorders Chapter
January 2022 – Present
Saudi Neurology Society, Saudi Commission For Health Specialties, Riyadh, Saudi Arabia

Deputy Chairperson, Department of Neuroscience
October 2020 – June 2021
King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Director, Movement Disorders Program
January 2017 – June 2023
Department of Neurosciences, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Director, Movement Disorders Fellowship Program
January 2019 – Present
Department of Neurosciences, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Movement Disorder Consultant
July 2015 – Present
Department of Neurosciences, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Fellow Physician
September 2014 – June 2015
Movement Disorder Center, CHU Grenoble, Grenoble, France

Fellow Physician
July 2012 – June 2014
Movement Disorder Center, Toronto Western Hospital, Toronto, Canada

Resident Physician
October 2007 – June 2012
Section of Neurology, Department of Neurosciences, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

EDUCATION

Executive MBA
January 2022 – June 2023
HEC Paris, Paris, France

Fellow, Surgical Movement Disorder Program
September 2014 – June 2015
Movement Disorder Center, CHU Grenoble, Grenoble, France

Chief Fellow, Movement Disorder Program
June 2013 – June 2014
Movement Disorder Center, Toronto Western Hospital, Toronto, Canada

Fellow, Movement Disorder Program
July 2012 – June 2014
Movement Disorder Center, Toronto Western Hospital, Toronto, Canada

Chief Resident in Neurology
August 2009 – June 2012
Department of Neurosciences, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Resident, Neurology Residency Training Program
October 2007 – July 2009
Department of Neurosciences, King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia

Medical Internship
September 2006 – August 2007
King Khalid University Hospital, Riyadh, Saudi Arabia

Doctor of Medicine (MBBS)
September 2001 – August 2006
King Saud University, Riyadh, Saudi Arabia

PUBLICATIONS AND RESEARCH INVOLVEMENT

Publications

1. Bohlega S, Abusrair AH, Al-Qahtani Z, Guzmán-Vega FJ, Ramakrishnan R, Aldosari H, Aldakheel A, Al-Qahtani S, Monies D, Arold ST. *Expanding the genotype-phenotype landscape of PDE10A-associated movement disorders.* Parkinsonism Relat Disord. 2023 Mar.

2. Bohlega SA, Abou-Al-Shaar H, AlDakheel A, Alajlan H, Bohlega BS, Meyer BF, Monies D, Cupler EJ, Al-Saif AM. *Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.* Parkinsonism Relat Disord. 2019 Jul.

3. AlDakheel A, Gasca-Salas C, Armstrong MJ, Duff-Canning S, Marras C. *Cognitive Complaints in Nondemented Parkinson’s Disease Patients and Their Close Contacts do not Predict Worse Cognitive Outcome.* Alzheimer Dis Assoc Disord. 2019 Apr.

4. Saeed Bohlega, Hussam Abou-Al-Shaar, Amaal AlDakheel, Huda Alajlan, Balsam Bohlega, Brain Meyer, Dorota Monies, Edward Cupler, Amr Al-Saif. *Autosomal recessive ADCY5-Related dystonia and myoclonus: Expanding the genetic spectrum of ADCY5-Related movement disorders.* Parkinsonism and Related Disorders. 2019 Feb.

5. Abusrair AH, Bohlega S, Al-Semari A, Al-Ajlan FS, Al-Ahmadi K, Mohamed B, AlDakheel A. *Brain MR Imaging Findings in Woodhouse-Sakati Syndrome.* AJNR. 2018 Dec.

6. Arora S, Visanji NP, Mestre TA, Tsanas A, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Lang AE, Little MA, Marras C. *Investigating Voice as a Biomarker for Leucine-Rich Repeat Kinase 2-Associated Parkinson’s Disease.* J Parkinsons Dis. 2018 Aug.

7. Van den Heuvel L, Lim AS, Visanji NP, Huang J, Ghate T, Mestre TA, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Pondal M, Faust-Socher A, Rogaeva E, Tomlinson G, Lang AE, Marras C. *Actigraphy Detects Greater Intra-Individual Variability During Gait in Non-Manifesting LRRK2 Mutation Carriers.* J Parkinsons Dis. 2018 Aug.

8. Visanji NP, Bhudhikanok GS, Mestre TA, Ghate T, Udupa K, AlDakheel A, Connolly BS, Gasca-Salas C, Kern DS, Jain J, Slow EJ, Faust-Socher A, Kim S, Valappil R, Kausar F, Rogaeva E, Langston J, Tanner CM, Schüle B, Lang AE, Goldman SM, Marras C. *Heart rate variability in leucine-rich repeat kinase 2-associated Parkinson’s disease.* Mov Disord. 2017 Jan.

9. Scelzo E, Lozano AM, Hamani C, Poon YY, Aldakheel A, Zadikoff C, Lang AE, Moro E. *Pedunculopontine nucleus stimulation in progressive supranuclear palsy: A randomized trial.* J Neurol Neurosurg Psychiatry. 2017 Feb 18.

10. Visanji NP, Marras C, Kern DS, AlDakheel A, Gao A, Liu LW, Lang AE, Hazrati LN. *Colonic mucosal α-synuclein lacks specificity as a biomarker for Parkinson’s disease.* Neurology. 2015 Feb 10; 84(6):609-16.

11. AlDakheel A, Beaulieu-Boire I, Fox SH. *Emerging drugs for levodopa-induced dyskinesia.* Expert Opin Emerg Drugs. 2014 Sep; 19(3):415-29.

12. Miyasaki J, AlDakheel A. *Movement Disorders in Pregnancy.* Continuum (Minneap Minn). 2014 Feb; 20(1):148-61.

13. AlDakheel A, Kalia LV, Lang AE. *Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease.* Neurotherapeutics. 2014 Jan; 11(1):6-23.

14. AlDakheel A, Phielipp N, Miyasaki J. *Evidence-based advances in the treatment of motor features of Parkinson’s disease.* Neurodegenerative Disease Management. 2013; 3(4):331-341.

Ongoing Research

– Deep Brain Stimulation in Woodhouse Sakati Syndrome: A Single Institution Retrospective Analysis
– Long-term Outcomes (+10 years) after GPI-DBS in Patients with Dystonia: A Large Tertiary-Care Institutional Analysis

PEAKER IN COURSES, CONFERENCES, AND SYMPOSIA

– *MDS-AOS Skills Workshop in Movement Disorders* – Speaker, Abu Dhabi, UAE, November 5-6, 2022
– *LCIG Exchange Program in Parkinson’s Disease* – Director, Riyadh, Saudi Arabia, May 13-14, 2022
– *Infusion Therapy in Parkinson’s Disease* – Speaker, Al Khobar, Saudi Arabia, February 25-26, 2022
– *Parade of Rare Movement Disorders in Asia* – Speaker, MDS-AOS 3rd School for Young Neurologists, Online, October 15-17, 2021
– *LCIG Exchange Program in Parkinson’s Disease* – Director, Riyadh, Saudi Arabia, December 5, 2020
– *1st Symposium of Neurological Issues in Women* – Speaker, Jeddah, Saudi Arabia, February 7-8, 2020
– *4th Middle East Camp for Parkinson’s, Movement Disorders, and Neuromodulation Course* – Speaker, Dubai, UAE, December 13-14, 2019
– *LCIG Exchange Program in Parkinson’s Disease* – Director, Riyadh, Saudi Arabia, November 21-22, 2019
– *XXIV World Congress of